ERBB2 and breast cancer: We used MDA-MB-231 breast cancer cells in this study as a representative model of a basal-like, triple negative breast cancer subtype, negative for estrogen receptor (ER), progesterone receptor (PR), human epidural growth factor receptor 2 (HER2), and E-cadherin expression [58,59,60].